Gulkas Pharma Pvt Ltd
About Gulkas Pharma Pvt Ltd
Data last updated:
Gulkas Pharma Pvt Ltd is a private limited company based in Kalol, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 December 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1990PTC014826. Its GSTIN is 24AAACG8004F1Z4 (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.85 Lakh. It is led by directors including Hasanabbas Gulamabbas Kadiwala and Gulamabbas Rahimbhai Kadiwala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kalol, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.78 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹11.53 Lakh (net margin 0.6%) and EBITDA of ₹38.4 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹1.01 Cr and satisfied charges of ₹69.31 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Gulkas Pharma Pvt Ltd's registered office is in Kalol, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered AddressPlot No 914, Phase I GIDC Chhatral, Kalol, Gujarat, India – 382729
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Gulkas Pharma Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gulkas Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Gulkas Pharma Pvt Ltd, buy the company report.
Financials of Gulkas Pharma Pvt Ltd
FY 2025 filings availableGulkas Pharma Pvt Ltd reported revenue of ₹18.78 Cr (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 21% growth in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹38.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gulkas Pharma Pvt Ltd, buy the company report.
Board of directors of Gulkas Pharma Pvt Ltd
Gulkas Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hasanabbas Gulamabbas Kadiwala | Director | 15 Oct 2003 | 23 Years 0 Months | Current |
| Gulamabbas Rahimbhai Kadiwala | Director | 28 Dec 1990 | 35 Years 10 Months | Current |
| Kasamali Jamalbhai Charolia | Director | 28 Dec 1990 | 35 Years 10 Months | Current |
| Zulfikarali Kasambhai Charolia | Director | 25 Nov 2003 | 22 Years 11 Months | Current |
Peer comparison
Gulkas Pharma Pvt Ltd is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kee Pharma Limited | ₹18.89 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Santiago Life Sciences Private Limited | ₹18.88 Cr (FY 2024) | 5.0% | Jabalpur, Madhya Pradesh, India | |||
| Indu Drugs Private Limited | ₹18.78 Cr (FY 2025) | -10.0% | Hyderabad, Telangana, India | |||
| Gulkas Pharma Pvt Ltdthis company | ₹18.78 Cr (FY 2025) | ₹11.53 Lakh | 0.6% | 21.0% | Kalol, Gujarat, India | |
| Medilife Impex Private Limited | ₹18.66 Cr (FY 2025) | 3.0% | Hingna, Maharashtra, India |
To see the full peer comparison of Gulkas Pharma Pvt Ltd, buy the company report.
Auditor
Gulkas Pharma Pvt Ltd is audited by RANGWALA AND CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RANGWALA AND CO | FY 2024 | 115833W |
Shareholding
The shareholding of Gulkas Pharma Pvt Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Gulkas Pharma Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 May 2019 | 100268811 | Axis Bank Limited | ₹1 Cr | Open | |
| 24 Oct 1990 | 90111135 | State Bank of Saurashtra | ₹1.4 Lakh | Open | |
| 21 Nov 2005 | 80024121 | Sidbi | ₹26.5 Lakh | Satisfied | |
| 21 Nov 2005 | 80024132 | Sidbi | ₹26.5 Lakh | Satisfied | |
| 10 May 1997 | 90111360 | State Bank of Saurashtra | ₹8 Lakh | Satisfied |
To see the full charge records of Gulkas Pharma Pvt Ltd, buy the company report.
Total charge records: 6 View all charges
Legal cases
Gulkas Pharma Pvt Ltd has 2 court cases on record: 2 filed by Gulkas Pharma. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, GANDHINAGAR, Gujarat | Court case (SMST R) | Filed by the company against Shwet Biotech Private Limited and 3 others | Pending |
| District court, GANDHINAGAR, Gujarat | Court case (CR A) | Filed by the company against Santosh Ranjitsing Director Swet Biotech Pvt. Ltd. and 1 other | Disposed |
To see the full case history of Gulkas Pharma Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Gulkas Pharma Pvt Ltd has 5 MSME Form 1 returns on record between 2021 and 2023, listing 14 overdue payments to 11 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 11)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Nill | |||
| an individual supplier | |||
| R J Plast Pack | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Gulkas Pharma Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Gulkas Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACG8004F1Z4 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gulkas Pharma Pvt Ltd, buy the company report.
Recent activity
Gulkas Pharma Pvt Ltd has 4 board changes on record since 1990: 4 appointments. The latest: Zulfikarali Kasambhai Charolia was appointed as Director on 25 Nov 2003.
7 earlier events are in the company report.
Frequently asked questions
Gulkas Pharma is an active private limited company based in Kalol, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 December 1990 (36+ years old) and is registered under CIN U24230GJ1990PTC014826.
Gulkas Pharma has 4 current directors:
- Hasanabbas Gulamabbas Kadiwala - Director
- Gulamabbas Rahimbhai Kadiwala - Director
- Kasamali Jamalbhai Charolia - Director
- Zulfikarali Kasambhai Charolia - Director
The latest financial statements of Gulkas Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Gulkas Pharma is 24AAACG8004F1Z4, registered in Gujarat.
The CIN (Corporate Identification Number) of Gulkas Pharma is U24230GJ1990PTC014826. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gulkas Pharma has 2 court cases on record: 2 filed by the company. 1 is pending.
Gulkas Pharma was incorporated on 28 December 1990, making it 36+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Gulkas Pharma by revenue are Kee Pharma Limited, Santiago Life Sciences Private Limited, Indu Drugs Private Limited, Medilife Impex Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Zulfikarali Kasambhai Charolia was appointed as Director on 25 Nov 2003. Hasanabbas Gulamabbas Kadiwala was appointed as Director on 15 Oct 2003. Gulamabbas Rahimbhai Kadiwala was appointed as Director on 28 Dec 1990. Gulkas Pharma has 4 board changes on record in total.
Gulkas Pharma has 5 MSME Form 1 returns on record between 2021 and 2023, listing 14 overdue payments to 11 micro and small suppliers. The latest return was filed on 28 Aug 2023.
The registered office of Gulkas Pharma is at Plot No 914, Phase I GIDC Chhatral, Kalol, Gujarat, India – 382729.
Gulkas Pharma operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
